MFDS — authorised 29 December 1989
- Marketing authorisation holder: BRACCO
- Status: likely_approved
🇰🇷 Rubidium Chloride Rb 82 in South Korea
MFDS authorised Rubidium Chloride Rb 82 on 29 December 1989
Marketing authorisation
Rubidium Chloride Rb 82 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Rubidium Chloride Rb 82 approved in South Korea?
Yes. MFDS authorised it on 29 December 1989.
Who is the marketing authorisation holder for Rubidium Chloride Rb 82 in South Korea?
BRACCO holds the South Korean marketing authorisation.